Skip to Main Content

Author Details

Abel Gonzalez-Perez
Universitat Pompeu Fabra
2005
69
33
PMIDPaper TitleJournal TitlePublished Year
36928603Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.Nat Genet2023
36697832Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.Nature2023
36780550Copy number footprints of platinum-based anticancer therapies.PLoS Genet2023
34718417DeepMP: a deep learning tool to detect DNA base modifications on Nanopore sequencing data.Bioinformatics2022
35871184Discovering the drivers of clonal hematopoiesis.Nat Commun2022
36071033High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER<sup>+</sup> breast cancer.Nat Commun2022
36264838Ten simple rules for a successful international consortium in big data omics.PLoS Comput Biol2022
36376284Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER<sup>+</sup> breast cancer.Nat Commun2022
33347579Variable interplay of UV-induced DNA damage and repair at transcription factor binding sites.Nucleic Acids Res2021
34493867Genomic and evolutionary classification of lung cancer in never smokers.Nat Genet2021
34376657The evolution of hematopoietic cells under cancer therapy.Nat Commun2021
34321661In silico saturation mutagenesis of cancer genes.Nature2021
31462706LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells.Oncogene2020
35121836Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer.Nat Cancer2020
33225950The evolution of relapse of adult T cell acute lymphoblastic leukemia.Genome Biol2020
33128047Are carcinogens direct mutagens?Nat Genet2020
32592465BnpC: Bayesian non-parametric clustering of single-cell mutation profiles.Bioinformatics2020
32778778A compendium of mutational cancer driver genes.Nat Rev Cancer2020
30523021NK Cell Infiltrates and HLA Class I Expression in Primary HER2<sup>+</sup> Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival.Clin Cancer Res2019
31740835The mutational footprints of cancer therapies.Nat Genet2019
31491604Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.Eur J Cancer2019
31228182OncodriveCLUSTL: a sequence-based clustering method to identify cancer drivers.Bioinformatics2019
31369060OncodriveCLUSTL: a sequence-based clustering method to identify cancer drivers.Bioinformatics2019
30901533Local Determinants of the Mutational Landscape of the Human Genome.Cell2019
29023197Mutational landscape of RNA-binding proteins in human cancers.RNA Biol2018
29973711Author Correction: Reduced mutation rate in exons due to differential mismatch repair.Nat Genet2018
30096302Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
30041662Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.J Hematol Oncol2018
30065304Manic Fringe deficiency imposes Jagged1 addiction to intestinal tumor cells.Nat Commun2018
30137196A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).Ann Oncol2018
30319692Network, Transcriptomic and Genomic Features Differentiate Genes Relevant for Drug Response.Front Genet2018
30388444Somatic and Germline Mutation Periodicity Follow the Orientation of the DNA Minor Groove around Nucleosomes.Cell2018
29666300A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations.Clin Cancer Res2018
29625053Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
29592813Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations.Genome Med2018
29106418Reduced mutation rate in exons due to differential mismatch repair.Nat Genet2017
27075101Nucleotide excision repair is impaired by binding of transcription factors to DNA.Nature2016
27716338Rational design of cancer gene panels with OncoPaD.Genome Med2016
27404455Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma.Br J Cancer2016
27311963OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations.Genome Biol2016
27095575Altered oncomodules underlie chromatin regulatory factors driver mutations.Oncotarget2016
26792175Circuits of cancer drivers revealed by convergent misregulation of transcription factor targets across tumor types.Genome Med2016
27080396Uncovering disease mechanisms through network biology in the era of Next Generation Sequencing.Sci Rep2016
25501392Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.Nat Genet2015
26125594Pathway and network analysis of cancer genomes.Nat Methods2015
25759023In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities.Cancer Cell2015
25823659Cytoplasmic accumulation of NCoR in malignant melanoma: consequences of altered gene repression and prognostic significance.Oncotarget2015
24265505Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia.Genome Res2014
25161246OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action.Bioinformatics2014
23363777Visualizing multidimensional cancer genomics data.Genome Med2013
  • 1 - 50 of 69

Recommended Authors

Hui Yu
Sylvester Comprehensive Cancer Center, University of Miami
Career Start Year 2017
Number of shared co-authors 1
Daniel H??bschmann
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Career Start Year 2016
Number of shared co-authors 13
Marco Mina
University of Lausanne, Switzerland Swiss Cancer Center Leman
Career Start Year 2012
Number of shared co-authors 12
Yuan Yuan
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 10
Hyunchul Jung
Wellcome Sanger Institute
Career Start Year 2009
Number of shared co-authors 4
Joshua F McMichael
Washington University
Career Start Year 2009
Number of shared co-authors 29
Giovanni Ciriello
University of Lausanne (UNIL)
Career Start Year 2008
Number of shared co-authors 25
Sigve Nakken
University of Oslo
Career Start Year 2007
Number of shared co-authors 16
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 21
Moritz Gerstung
German Cancer Research Centre DKFZ
Career Start Year 2007
Number of shared co-authors 9
Xiaotu Ma
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 7
Jeroen de Ridder
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year 2006
Number of shared co-authors 10
Harmen J G van de Werken
Department of Immunology Erasmus University Medical Center
Career Start Year 2006
Number of shared co-authors 7
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 13
Matthias Schlesner
University of Augsburg
Career Start Year 2004
Number of shared co-authors 28
Matthew D Wilkerson
Uniformed Services University of the Health Sciences
Career Start Year 2004
Number of shared co-authors 21
Kai Wang
Pfizer Inc.
Career Start Year 2004
Number of shared co-authors 1
Keiran Raine
Wellcome Sanger Institute
Career Start Year 2004
Number of shared co-authors 28
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 23
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 21
F??tima Al-Shahrour
Spanish National Cancer Research Centre (CNIO)
Career Start Year 2003
Number of shared co-authors 8
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 3
Amy G Robertson
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 31
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 18
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 26
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 1
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 1
Steven J M Jones
University of British Columbia
Career Start Year 1995
Number of shared co-authors 41
Andrea Califano
Columbia University
Career Start Year 1993
Number of shared co-authors 17
Fran Supek
Catalan Institution for Research and Advanced Studies (ICREA)
Career Start Year 1992
Number of shared co-authors 2

Collaborators

Nuria Lopez-Bigas
Universitat Pompeu Fabra
Co-authored papers 50
David Tamborero
Universitat Pompeu Fabra
Co-authored papers 15
Jordi Deu-Pons
Institute for Research in Biomedicine
Co-authored papers 9
Ana Tereza Ribeiro de Vasconcelos
The National Laboratory for Scientific Computing (LNCC)
Co-authored papers 8
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers 6
Joan Albanell
Hospital del Mar Research Institute
Co-authored papers 5
Michael S Lawrence
Co-authored papers 5
Rodrigo Dienstmann
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus
Co-authored papers 5
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 5
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 5
Francisco Mart??nez-Jim??nez
Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht
Co-authored papers 4
J??ri Reimand
Ontario Institute for Cancer Research
Co-authored papers 4
Ken Chen
University of Texas MD Anderson Cancer Center
Co-authored papers 3
David A Wheeler
Baylor College of Medicine
Co-authored papers 3
Benjamin J Raphael
Princeton University
Co-authored papers 3
Gary D Bader
University of Toronto
Co-authored papers 3
Rachel Karchin
Johns Hopkins University
Co-authored papers 3
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 3
Alfonso Valencia
Josep Carreras Leukaemia Research Institute (IJC)
Co-authored papers 3
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 3
Jaegil Kim
Co-authored papers 3
Chris Sander
Broad Institute of MIT and Harvard
Co-authored papers 3
Julian M Hess
Broad Institute of MIT and Harvard
Co-authored papers 3
Tatsuhiro Shibata
Kurume University School of Medicine
Co-authored papers 2
Ville Mustonen
University of Helsinki
Co-authored papers 2
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 2
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 2
Matthew H Bailey
Department of Biology at Brigham Young University
Co-authored papers 2
Rune Linding
Humboldt-Universitat zu Berlin
Co-authored papers 2
Hannah Carter
University of California San Diego
Co-authored papers 2
Release 1.2